-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - inhibitor (ramipril) and ARB (telmisartan)
therapy are directly compared, there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication … inhibitor (ramipril) and ARB (telmisartan)
therapy are directly compared, there is a nonsignificant
indication … combination therapy with ACE inhibitors and ARBs
(ramipril + telmisartan), there is a nonsignificant
indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Analysis
We classified hospitalizations where rFVIIa use was
reported into discrete, mutually exclusive indication … denominator of potential rFVIIa usage (i.e., total number
of patients eligible for use) by specific clinical
indication … evaluated the applicability
to real-world practice of the total body of evidence
within a given clinical indication … thereby
compromised by small study size, use of indirect
outcomes, and heterogeneity in dosage and indication … diminished by less acutely ill
patients and a mismatch between existing research and
real-world patterns of indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - Choice of
technique may depend on factors including the underlying indication for surgery … Regardless of indication, age may affect outcomes markedly in tonsillectomy;; younger children … Other comments suggested presenting results by
subgroup when possible (e.g., indication for … growth information,
and conditions such as Down Syndrome
• Operational definition of indication … important to describe will include age, BMI, variability in definition or
characterization of indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - exemption approval for OCD, which marked the first FDA
approval of any DBS device for a psychiatric indication … drug and improve the efficacy ‘signal.’ ”
6
FDA has granted the agent fast
track status for this indication … device exemption, which was the first FDA approval of any kind for a DBS device for
a psychiatric indication … sometimes abused as a street drug (“Special K”), which may affect the regulatory pathway for this
indication … HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - Food and Drug
Administration (FDA) approval of any DBS device for a psychiatric indication. … device exemption, which was the first FDA approval of any kind for a DBS device for a
psychiatric indication … These experts
were confident that, if available for use in this indication, ketamine has potential … clinically significant blood pressure increases.”
54
Although MAPS is conducting the studies for this indication … HDE approval to
commercialize the first deep brain stimulation
(DBS) therapy for a psychiatric indication
-
effectivehealthcare-admin.ahrq.gov/products/instrumental-variable-methods/research
January 01, 2019 - medication is used preferentially in patients with the poorest prognosis, confounding by unmeasured indication … there were an unmeasured variable that was a component of both ε 1 and ε 2 —e.g., an unrecorded indication … Here, substantial uncontrolled confounding is likely due to confounding by indication or confounding … Combining ecological and individual variables to reduce confounding by indication: case study--subarachnoid … Confounding by indication. Epidemiology 1996;7:335-336.
56. Angrist JD, Krueger AB.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
December 05, 2018 - evidence on psychotropic
medications in pregnant or breastfeeding women is “historically lacking” for any indication … However, confounding by indication and underlying disease severity remain
concerns. … comparison cohorts, and
statistical testing.36
All observational studies are subject to confounding by indication—that … who are not
receiving treatment.37 However, this approach does not entirely address confounding by
indication
-
effectivehealthcare-admin.ahrq.gov/products/mental-health-pregnancy/protocol
January 01, 2020 - evidence on psychotropic medications in pregnant or breastfeeding women is "historically lacking" for any indication … However, confounding by indication and underlying disease severity remain concerns. … comparison cohorts, and statistical testing. 36
All observational studies are subject to confounding by indication—that … who are not receiving treatment. 37 However, this approach does not entirely address confounding by indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - Each of the target populations for
each reviewed indication is explicitly defined. … the data were primarily taken from industry-sponsored
clinical trials for one drug for one specific indication … comment,
but left the data in the report
since other atypicals have not
been FDA approved for this
indication … Similarly, our summary table of
benefits (Table 1) lists each
drug seperately for each
indication.
-
effectivehealthcare-admin.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research
December 01, 2019 - Both RCTs reported that Hct remained in the targeted ranges (an indication for the adequacy of anemia
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
August 01, 2012 - for their
use; and second that, among patients with another indication,
those with CKD have a relatively … One could argue that if
patients are being treated for a non-CKD
indication (e.g. hypertension) and … are not
at treatment goal for that indication, no
additional information regarding CKD
status should … As stated above, if patients are being
treated for a non-CKD indication (e.g. … hypertension) and are not at treatment
goal for that indication, no additional
information regarding
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - I
couldn’t find an indication that outcome definitions were assessed
for rigidity or consistency (MI … for apixaban,
rivaroxaban and dabigatran because the question
clearly stated “In patients with an indication … We have kept prasugrel in the table since it was
studied for this indication. … We have kept prasugrel in the table since it was
studied for this indication. … We did not have a Key Question regarding the use
of oral anticoagulation (without an indication for
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
May 01, 2013 - States,
and are either FDA approved for VTE prophylaxis or are
used off label by clinicians for this indication … and
clopidogrel; as well as the anticoagulant warfarin, which
clinicians may use off label for this indication … The greatest
risk to their validity was confounding by indication in
that the sicker patients received … information that would need to
be captured would be filter-related information including
timing, indication … Future research using high-quality observational studies
that control for confounding by indication,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - , one manufacturer is studying esketamine, the purified
(S)-enantiomer form of ketamine, for this indication … No scopolamine manufacturers are sponsoring registered clinical trials for this
indication. … FDA has granted
fast-track status to esketamine for this indication, and Janssen plans to also apply … behaviors, and delusions.67,76,77
Three registered clinical trials are ongoing for this off-label indication … Five experts, with clinical and research backgrounds, commented on off-label scopolamine for
this indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
April 01, 2010 - medication is used preferentially in patients with the poorest prognosis, confounding by
unmeasured indication … occur if there were an unmeasured variable that was a
component of both 1 and 2—e.g., an unrecorded indication … Here,
substantial uncontrolled confounding is likely due to confounding by indication or confounding … Combining ecological and
individual variables to reduce confounding
by indication: case study--subarachnoid … Confounding by indication.
Epidemiology 1996;7:335-336.
56. Angrist JD, Krueger AB.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - inclusion, all available medical and statistical reviews
for all drugs under consideration, regardless of indication … the database, but also because the actual clinical data within
the reviews may cover more than one indication … and harms data are of importance regardless of
indication. … effectiveness.53
While a search for studies about effectiveness would include only studies of the indication … interest, harms data should not be limited in this way; data about harms is of interest regardless
of indication
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-finding-evidence/methods
December 01, 2019 - inclusion, all available medical and statistical reviews for all drugs under consideration, regardless of indication … the database, but also because the actual clinical data within the reviews may cover more than one indication … and harms data are of importance regardless of indication. … effectiveness. 53 While a search for studies about effectiveness would include only studies of the indication … interest, harms data should not be limited in this way; data about harms is of interest regardless of indication
-
effectivehealthcare-admin.ahrq.gov/products/prehospital-airway-management/research
August 01, 2021 - Due to the dynamic nature of the prehospital environment, the results are susceptible to indication and
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - For
this indication, rifaximin’s FDA-approved, labeling recommends one 550 mg tablet, taken 3
times … However, alosetron has a labeled
indication for use only in women. … .1,10-13 Before rifaximin’s May 2015 approval, only
one drug, alosetron, had an FDA-approved, labeled indication
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
January 01, 2012 - ”
“Blood in
the stool
is an indication
of several
serious diseases.”
The most common